Sex-specific differences in reproductive tract lymphomas: epidemiology, clinical features, and treatment outcomes
The Oncologist · 2025
DOI: 10.1093/oncolo/oyaf102 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Shan Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology-Oncology, Fujian Children's Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medica…. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Lymphoma. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fujian Provincial Natural Science Foundation of China, Subsidy Funds for Medical Double-high Project of Fujian Province, Fujian Children's Hospital Cultivation Project.
Abstract (Originalsprache)
Background
The differences in the epidemiology, clinical characteristics, and treatment strategies between primary lymphoma of the female reproductive tract (PLFGT) and primary lymphoma of the male reproductive tract (PLMGT) remain unclear. Materials and Methods A retrospective analysis of PLFGT and PLMGT data from the surveillance, epidemiology, and end results database spanning 2000 to 2021 was conducted to compare the differences in incidence rates and clinical indicators. Bar chart analysis highlighted the distribution differences between lymphoma subgroups. Multivariate Cox regression models were used to identify prognostic factors. Kaplan–Meier analysis was performed to evaluate prognostic survival outcomes.
Results
Data from 724 patients with PLFGT and 2025 with PLMGT were analyzed, with diffuse large B-cell lymphoma (DLBCL) being the most prevalent subtype. The incidence of PLFGT was higher than that of PLMGT; however, the incidence rates in both groups decreased. Among DLBCL cases, the testis was the most frequent primary site in men, whereas the ovary predominated in women with follicular lymphoma. The prognostic risk factors for PLFGT included age, pathological type, primary site, surgery, and chemotherapy, whereas those for PLMGT include age, pathological type, chemotherapy, and radiation. In the DLBCL subtype of PLFGT in the study, combined chemotherapy and radiation reportedly enhance cancer-specific survival in patients in a limited stage (Ann Arbor stage I and II). In contrast, for patients with an advanced stage (Ann Arbor stage III and IV), combined chemotherapy and surgery yielded the most favorable survival outcomes. In the DLBCL subtype of PLMGT, combined chemotherapy, radiation, and surgery demonstrated the most effective therapeutic outcomes across both the limited and advanced stages.
Conclusions
Clinical differences were observed between PLFGT and PLMGT. Prompt and accurate identification of risk factors and implementing integrated treatment strategies are essential for optimizing patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology-Oncology, Fujian Children's Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
- Department of Hematology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
- Department of Radiation Oncology, Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Ra…
ORCID-Profile: Yaobin Lin
Förderung
- Fujian Provincial Natural Science Foundation of China
- Subsidy Funds for Medical Double-high Project of Fujian Province
- Fujian Children's Hospital Cultivation Project
- Joint Funds for the Innovation of Science and Technology
- Fujian Children’s Hospital Cultivation Project
Zitieren
APA
Liu, S., Shang, J., & Lin, Y. (2025). Sex-specific differences in reproductive tract lymphomas: epidemiology, clinical features, and treatment outcomes. The Oncologist. https://doi.org/10.1093/oncolo/oyaf102
Vancouver
Liu S, Shang J, Lin Y. Sex-specific differences in reproductive tract lymphomas: epidemiology, clinical features, and treatment outcomes. The Oncologist. 2025. doi:10.1093/oncolo/oyaf102
BibTeX
@article{Liu2025,
author = {Liu, Shan and Shang, Jin and Lin, Yaobin},
title = {Sex-specific differences in reproductive tract lymphomas: epidemiology, clinical features, and treatment outcomes},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyaf102}
}
EUVIMED